Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line

British Journal of Cancer

Volumn 79, Issue 5-6, 1999, Pages 693-700

  Parisot, J P ^a   Hu, X F ^a   DeLuise, M ^b   Zalcberg, J R ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b AUSTIN HEALTH   (Australia)

Author keywords

Breast cancer; IGF 1R; Oestrogen; Tamoxifen resistance

Indexed keywords

ESTROGEN; MONOCLONAL ANTIBODY; SOMATOMEDIN; SOMATOMEDIN C RECEPTOR; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL GROWTH; CELL STRAIN MCF 7; CELL SURVIVAL; CONTROLLED STUDY; GROWTH STIMULATION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIZATION; SERUM;

BREAST NEOPLASMS; CELL DIVISION; CLONE CELLS; CULTURE MEDIA, SERUM-FREE; DRUG RESISTANCE, NEOPLASM; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; KINETICS; RECEPTOR, IGF TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TAMOXIFEN; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0033001742     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690112     Document Type: Article

References (47)

1. Arteaga CL and Osborne CK (1989) Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor. Cancer Res 49: 6237-6241
2. Baserga R, Hongo A, Rubini M, Prisco M and Valentinis B (1997) The IGF-1 receptor in cell growth, transformation and apoptosis. Biochim Biophys Acta 1332: F105-F126
3. Berthois Y, Katzenellenbogen J and Katzenellenbogen B (1986) Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci USA 83: 2496-2500
4. Chomczynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159
5. Clarke R, Howell A and Anderson E (1997) Type I insulin-like growth factor receptor gene expression in normal human breast tissue treated with oestrogen and progesterone. Br J Cancer 75: 251-257
6. Darbre P, Yates J, Curtis S and King R (1983) Effect of estradiol on human breast cancer cells in culture. Cancer Res 43: 349-354
7. Decupis A, Noonan D, Pirani P, Ferrera A, Clerico L and Favoni RE (1995) Comparison between novel steroid-like and conventional nonsteroidal antioestrogens in inhibiting oestradiol-and IGF-1-induced proliferation of human breast cancer-derived cells. Br J Pharmacol 116: 2391-2400
8. Dickson RB, Johnson MD, el Ashry D, Shi YE, Bano M, Zugmaier G, Ziff B, Lippman ME and Chrysogelos S (1993) Breast cancer: influence of endocrine hormones, growth factors and genetic alterations. Adv Exp Med Biol 330: 119-141
9. Dunn S, Hardman R, Kari F and Barrett J (1997) Insulin-like growth factor I (IGF-1) alters drug sensitivity of HBL 100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs. Cancer Res 57: 2687-2693
10. Encarnacion CA and Fuqua SA (1994) Oestrogen receptor variants in breast cancer. Cancer Treat Res 71: 97-109
11. Freiss G, Rochefort H and Vignon F (1990) Mechanisms of 4-hydroxytamoxifen anti-growth factor activity in breast cancer cells: alterations of growth factor receptor binding sites and tyrosine kinase activity. Biochem Biophys Res Commun 173: 919-926
12. Hu XF, Veroni M, De Luise M, Wakeling A, Sutherland R, Watts CK and Zalcberg JR (1993) Circumvention of tamoxifen resistance by the pure antioestrogen ICI 182,780. Int J Cancer 55: 873-876
13. Huff K, Kaufman D, Gabbay KH, Spencer EM, Lippman ME and Dickson RB (1986) Secretion of an insulin-like growth factor-I-related protein by human breast cancer cells. Cancer Res 46: 4613-4619
14. Huynh H, Nickerson T, Pollak M and Yang XF (1996) Regulation of insulin-like growth factor I receptor expression by the pure antioestrogen ICI 182,780. Clin Cancer Res 2: 2037-2042
15. Jones JI and Clemmons DR (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16: 3-34
16. Karey K and Sirbasku D (1988) Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol. Cancer Res 48: 4083-4092
17. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H. Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D and Chambon P (1995) Activation of the oestrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270: 1491-1494
18. Katzenellenbogen BS and Norman MJ (1990) Multihormonal regulation of the progesterone receptor in MCF-7 human breast cancer cells: interrelationships among insulin/insulin-like growth factor-I, serum, and oestrogen (published erratum appears in Endocrinology 1990; 126: 3217.) Endocrinology 126: 891-898
19. Kleinman D, Karas M, Roberts CJ, LeRoith D, Phillip M, Segev Y, Levy J and Sharoni Y (1995) Modulation of insulin-like growth factor I (IGF-1) receptors and membrane-associated IGF-binding proteins in endometrial cancer cells by estradiol. Endocrinology 136: 2531-2537
20. Kull-Jr FC, Jacobs S, Su Y, Svoboda M, Van Wyk J and Cuatrecasas P (1983) Monoclonal antibodies to receptors for insulin and somatomedin-C. J Biol Chem 258: 6561-6566
21. Lee AV and Yee D (1995) Insulin-like growth factors and breast cancer. Biomed Pharmacother 49: 415-421
22. Lee AV, Darbre P and King R (1994a) Processing of insulin-like growth factor-II (IGF-II) by human breast cancer cells. Mol Cell Endocrinol 99: 211-220
23. Lee AV, Toi M and Yee D (1994b) Tamoxifen resistant MCF 7 cells exhibit increased expression of insulin-like growth factor-II (IGF-II). Breast Cancer Res Treat 32S: 57
24. Lippman ME (1985) Growth regulation of human breast cancer. Clin Res 47: 375-382
25. McCotter D, Vandenberg HW, Boylan M and McKibben B (1996) Changes in insulin-like growth factor-I receptor expression and binding protein secretion associated with tamoxifen resistance and oestrogen independence in human breast cancer cells in vitro. Cancer Lett 99: 239-245
26. Musgrove EA and Sutherland RL (1993) Acute effects of growth factors on T47D breast cancer cell cycle progression. Eur J Cancer 29A: 2273-2279
27. Newton CJ, Trapp T, Pagotto U, Renner U, Buric R and Stalla GK (1994) The oestrogen receptor modulates growth of pituitary tumour cells in the absence of exogenous oestrogen. J Mol Endocrinol 12: 303-312
28. Osborne C, Coronado EB, Kitten LJ, Arteaga CL, Fuqua SA, Ramasharma K, Marshall M and Li CH (1989) Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-1 receptor. Mol Endocrinol 3: 1701-1709
29. Papa V, Gliozzo B, Clark GM, McGuire WL, Moore D, Fujitayamaguchi Y, Vigneri R, Goldfine ID and Pezzino V (1993) Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer. Cancer Res 53: 3736-3740
30. Parisot JP, Hu XF, Sutherland R, Wakeling A, Zalcberg J and DeLuise M (1995) The pure antioestrogen ICI 182,780 binds to a high-affinity site distinct from the oestrogen receptor. Int J Cancer 62: 480-484
31. Pekonen F, Partanen S, Makinen T and Rutanen E (1988) Receptors for epidermal growth factor and insulin-like growth factor I and their relation to steroid receptors in human breast cancer. Cancer Res 48: 1343-1347
32. Peyrat J, Bonneterre J, Hecquet B, Vennin P, Louchez M, Fournier C, Lefebvre J and Demaille A (1993) Plasma insulin-like growth factor-I (IGF-1) concentrations in human breast cancer. Eur J Cancer 29A: 492-497
33. Quinn KA, Treston AM, Unsworth EJ, Miller MJ, Vos M, Grimley C, Battey J, Mulshine JL and Cuttitta F (1996) Insulin-like growth factor expression in human cancer cell lines. J Biol Chem 271: 11477-11483
34. Reddel RR, Alexander IE, Masfumi K, Shine J and Sutherland R (1988) Genetic instability and the development of steroid hormone insensitivity in cultured T47D human breast cancer cells. Cancer Res 48: 4340-4347
35. Resnicoff M, Abraham D, Yutanawiboonchai W, Rotman HL, Kajstura J, Rubin R, Zoltick P and Baserga R (1995) The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res 55: 2463-2469
36. Rohlik Q, Adams D, Kull FC Jr and Jacobs S (1987) An antibody to the receptor for insulin-like growth factor I inhibits the growth of MCF-7 cells in tissue culture. Biochem Biophys Res Commun 149: 276-281
37. Steele-Perkins G, Turner J, Edman JC, Hari J, Pierce SB, Stover C, Rutter WJ and Roth RA (1988) Expression and characterization of a functional human insulin-like growth factor I receptor. J Biol Chem 263: 11486-11492
38. Stewart AJ, Johnson MD, May FE and Westley B (1990) Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the oestrogen-stimulated proliferation of human breast cancer cells. J Biol Chem 265: 21172-21178
39. Stewart AJ, Westley B and May F (1992) Modulation of the proliferative response of breast cancer cells to growth factors by oestrogen. Br J Cancer 66: 640-648
40. Thorsen T, Lahooti H, Rasmussen M and Aakvaag A (1992) Oestradiol treatment increases the sensitivity of MCF-7 cells for the growth stimulatory effect of IGF-1. J Steroid Biochem Mol Biol 41: 537-540
41. Toi M, Harris A and Bicknell R (1993) cDNA transfection followed by the isolation of a MCF-7 breast cell line resistant to tamoxifen in vitro and in vivo. Br J Cancer 68: 1088-1096
42. Ullrich A, Gray A, Tam A, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, Le Bon T, Kathuria S, Chen E et al (1986) Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 5: 2503-2512
43. van den Berg HW, Claffie D, Boylan M, McKillen J, Lynch M and McKibben B (1996) Expression of receptors for epidermal growth factor and insulin-like growth factor I by ZR-75-1 human breast cancer cell variants is inversely related - the effect of steroid hormones on insulin-like growth factor I receptor expression. Br J Cancer 73: 477-481
44. Werner H, Woloschak M, Adamo M, Shen-Orr Z, Roberts CT Jr and LeRoith D (1989) Developmental regulation of the rat insulin-like growth factor I receptor gene. Proc Natl Acad Sci USA 86: 7451-7455
45. Westley BR and May F (1994) Role of insulin-like growth factors in steroid modulated proliferation (Review). J Steroid Biochem Mol Biol 51: 1-9
46. Wiseman LR, Johnson MD, Wakeling AE, Lykkesfeldt AE, May FE and Westley BR (1993) Type I IGF receptor and acquired tamoxifen resistance in oestrogen-responsive human breast cancer cells. Eur J Cancer 29A: 2256-2264
47. Yee D, Cullen KJ, Paik S, Perdue JF, Hampton B, Schwartz A, Lippman ME and Rosen N (1988) Insulin-like growth factor II mRNA expression in human breast cancer. Cancer Res 48: 6691-6696